On Wednesday, May 22, 2013, the American Cancer Society will celebrate 100 years of saving lives and creating a world with more birthdays. The Society is using the historic milestone as an opportunity to encourage everyone to participate in a Moment Against Silence by pledging to do one thing to help finish the fight against cancer, such as making a donation, enrolling in the research study called Cancer Prevention Study-3 to help better understand how to prevent cancer, and making healthy choices to reduce cancer risk. For details, go to cancer.org/fight.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61110-american-cancer-society-acs-100th-birthday-events
Ann Taylor is proud to support The Breast Cancer Research Foundation® (BCRF) through the sale of the Ann Taylor Cares Card at Ann Taylor stores nationwide during the month of May. In addition, a set of three shades of pink nail polish will be available for purchase. 90% of the purchase price of the Ann Taylor Cares Card and 50% of the purchase price of the nail polish set will be donated to BCRF.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58230-ann-taylor-shop-support-breast-cancer-research-foundation-pink-nail-polish
To promote the science behind obesity prevention and treatment, The Obesity Society (TOS) and the American Society for Metabolic and Bariatric Surgery (ASMBS) are combining resources to host the world’s pre-eminent meeting on obesity, ObesityWeek(SM) 2013, Nov. 11-16, at the Georgia World Congress Center in Atlanta, Georgia. For the first time, both organizations will co-locate their respective annual meetings under one roof for the most comprehensive agenda in obesity research, treatment and prevention.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55494-tos-and-asmbs-host-obesity-week-2013
Today’s superheroes don’t drive a Batmobile or fly through the air faster than the speed of light. Their capes are white lab coats and their superpower is the ability to cure. They are men and women researching cures for childhood cancer – the leading cause of death by disease in children under the age of 15 in the U.S.1- which is vastly underfunded.2
Starting today, Northwestern Mutual is giving consumers the chance to honor childhood cancer researchers and kids who are fighting cancer, by raising research funds through a new Facebook campaign, Heroes for a Cure. The Northwestern Mutual campaign aims to raise $50,000 – equal to 1,000 hours of research – in September, which is National Childhood Cancer Month.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59532-northwestern-mutual-launches-heroes-for-cure-campaign-fight-child-cancer
Investment in basic research, convergence across disciplines and better engagement between academia and industry are key to the future of innovation, according to a panel of renowned thought leaders speaking at the celebration of the 2013 Dr. Paul Janssen Award for Biomedical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63340-johnson-and-johnson-dr-paul-janssen-global-innovation-thermosensation
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced Accelrys Insight and Accelrys Insight for Excel, completing the roll-out of Accelrys’ next-generation cheminformatics suite and providing an interactive, collaborative environment for rapid and effective decision-making in drug discovery. Accelrys Insight and Accelrys Insight for Excel offer research scientists an entirely new way of accessing, visualizing and analyzing data that is locked in disparate locations across internal discovery teams and networked external partners, helping to lower long-standing barriers to bringing innovative therapeutics to market faster and more cost effectively.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62191-accelrys-insight-next-generation-decision-making-in-scientific-discovery
The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign is proud to announce its 2013 global Campaign for Breast Cancer Awareness Month and beyond. The 2013 theme, “Let’s Defeat Breast Cancer. We’re Stronger Together.”, is a call-to-action that will serve to shift public focus from awareness to increased action, advancing us further towards eradicating breast cancer from our lives. To date, The BCA Campaign has raised more than $48 million to support global research, education and medical services. This year’s BCA Campaign is committed to raising $5 million to support breast cancer research, education and medical services worldwide. Action doesn’t happen alone. When we join together…We’re Stronger Together.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63597-estee-lauder-elizabeth-hurley-breast-cancer-aware-campaign-aware-action
Lynn Napoli Marynowski and her younger brother Frank Napoli are as close as a big sister and little brother can be. They are an extension of their tight-knit family. From being raised together (along with a brother), to working together—Lynn has worked at the Chicago Mercantile Exchange for 25 years and Frank 17 years—and, to this day, still living nearby each other, their parents and brother in Chicago and surrounding suburbs, Lynn and Frank share a close sibling connection. So, when Lynn was struck with the diagnosis of Stage 3 breast cancer back in June 2012, that road—no matter how long—would also be theirs to travel together.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63625-northwestern-memorial-hospital-lynn-sage-cancer-research-foundation
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Weill Cornell Medical College today opened the Belfer Research Building, a state-of-the-art facility that ushers in a new era at the institution for cutting-edge, translational science. The 18-story, $650 million building, made possible through the generosity of numerous donors, nearly doubles Weill Cornell’s existing research space and empowers scientists to rapidly translate groundbreaking discoveries into the most advanced patient care.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65415-weill-cornell-medical-college-belfer-cancer-research-building-opening
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace. ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to maintain, ScienceCloud improves operational excellence in globally networked research, significantly reducing IT cost and effort.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65595-sciencecloud-software-by-accelrys-advances-collaborative-drug-discovery
High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65964-ccfa-genetic-microbiome-discoveries-ibd-crohn-s-disease-ulcerative-colitis
